Follow-Up of Ureteral Stones ≤4 mm

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-01

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the proportion of ureteral stones ≤4 mm that pass spontaneously within 4 and 8 weeks and assess if pain, blood test (S-creatinine), stone size, stone location and hydronephrosis can predict stone passage. The participants will be asked to fill in a questionare regarding symptoms, give a blood test and undergo a follow-up computed tomography.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections

NCT04495699

Urinary Tract Infections Kidney Stone

COMPLETED

Multicenter Study to Develop a Model to Identify Uric Acid Urinary Tract Stones Using CT and Lab Tests

NCT07328932

Urinary Tract Stones

ACTIVE_NOT_RECRUITING

Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones

NCT01514032

Kidney Stones

UNKNOWN NA

Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones

NCT06987760

Ureter Injury Urolithiasis; Lower Urinary Tract Efficacy, Self

RECRUITING NA

Bone Mineral Density and Vascular Calcifications in the Population of Lithiasis Patients With Idiopathic Hypercalciuria

NCT04770506

Hypercalciuria; Idiopathic

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients with a diagnosis of ureteral stone ≤4 mm at the Emergency Department in Helsingborg will be asked to participate. If they give consent data regarding age, gender, stone size, stone location, hydronephrosis, S-creatinine, treatments and results from the follow up CT is extraced from the medical records.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Follow-up with S-creatine, questionnaire and CT

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients with acute renal colic where a CT within 24 hours shows an ureteral stone ≤ 4mm and there is no need for acute intervention.

Exclusion Criteria

* Those who decline to participate, those who are put under guardianship or is less than 18 years old.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magnus Wagenius, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Lund

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Urology

Helsingborg, , Sweden

Site Status

Department of Urology, KI Huddinge

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-04897-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones

NCT05715086 RECRUITING NA

Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy

NCT02032316 COMPLETED PHASE1

The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones

NCT04071340 COMPLETED

Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

NCT02210650 COMPLETED NA

Prospective Relationship Between the Rates of Spontaneous Passage of Distal Ureteral Stones and the Distal Lumen

NCT05416502 UNKNOWN

A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

NCT03007160 UNKNOWN PHASE4

Urine Biomarker for Stone Recurrence

NCT04354181 COMPLETED

Can a Spot Urine Replace or Improve 24 Hour Urine Collections in Kidney Stone Patients

NCT01420354 TERMINATED

Ureteric Stenting Versus Non-stenting Following Uncomplicated Ureteroscopic Lithotripsy

NCT04145063 COMPLETED NA

Urine and Stool Analysis in Kidney Stone Disease

NCT01637506 UNKNOWN

Are the Stone Density and Location Useful Parameters for Small Kidney Stones?

NCT03503539 COMPLETED NA

Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial.

NCT04764071 UNKNOWN PHASE3

Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic Characterization

NCT05634434 UNKNOWN

The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

NCT01526304 UNKNOWN

Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease

NCT04697706 COMPLETED EARLY_PHASE1

Single-use Digital Flexible Ureteroscope vs Nondisposable Fiber Optic vs Digital Ureteroscope

NCT03220516 UNKNOWN NA

Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach

NCT05237063 RECRUITING NA

Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients

NCT05443932 NOT_YET_RECRUITING PHASE4

Medical Expulsive Therapy Post-SWL For Renal Stones

NCT05032287 COMPLETED NA

Comparison of CHOKAI vs STONE Score to Predict the Presence of Ureteric Stones in Patients With Renal Colic: A Multi-center Prospective Observational Study

NCT04759417 COMPLETED

Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Lithotripsy.

NCT05525130 COMPLETED NA

Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones

NCT03657667 COMPLETED NA

Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter'

NCT00517205 COMPLETED

Ultrasound Imaging of Kidney Stones and Lithotripsy

NCT02214836 ACTIVE_NOT_RECRUITING NA

Duration Between Drainage and Ureteroscopic Lithotripsy

NCT06101563 COMPLETED NA